Internal Medicine, Cardiovascular Disease · Lady Lake, FL
NPI
1457387888
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8550 NE 138th Ln Ste 401
Lady Lake, FL, 32159
Phone (352) 347-2315
Groups this clinician bills Medicare through
Medicare paid, 2024
$300K
4,130 services
Medicare patients, 2024
1,122
Average age 76
Drug cost, 2024
$1.1M
9,619 prescriptions
Company payments, 2025
$683
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali Nasser was code 99214 (office e&m - established), 957 times for 655 patients. In total Ali Nasser billed 4,130 services in 52 codes, and Medicare paid $300K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 957 | 655 | $90.98 | $87K |
| 93000 Electrocardiogram | Office | 666 | 608 | $10.33 | $6,881 |
| 99213 Office E&M - Established | Office | 337 | 286 | $63.34 | $21K |
| 93306 Echocardiography (TTE/TEE) | Office | 230 | 227 | $151.73 | $35K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 212 | 53 | $5.61 | $1,190 |
| 93294 External Electrocardiographic Monitoring | Office | 168 | 58 | $22.81 | $3,833 |
| 99204 Office E&M - New | Office | 146 | 146 | $123.02 | $18K |
| 85610 Clinical Chemistry | Office | 144 | 21 | $4.20 | $605 |
| 93306 Echocardiography (TTE/TEE) | Facility | 143 | 133 | $53.95 | $7,714 |
| 93015 Electrocardiogram | Office | 129 | 129 | $44.88 | $5,790 |
| 99215 Office E&M - Established | Office | 116 | 101 | $138.65 | $16K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 104 | 52 | $364.58 | $38K |
| 93010 Electrocardiogram | Facility | 76 | 60 | $6.52 | $495 |
| 78452 Myocardial Perfusion Scan | Office | 62 | 62 | $338.71 | $21K |
| 93297 External Electrocardiographic Monitoring | Office | 62 | 22 | $27.92 | $1,731 |
By year: 2022 $359K for 4,652 services; 2023 $320K for 4,369 services; 2024 $300K for 4,130 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 144 | 21 | $4.20 | $605 |
Medicare prescription drug claims, 2024
In 2024, the drug Ali Nasser prescribed most often to Medicare patients was Metoprolol Succinate, with 1,134 prescriptions and refills. In total Ali Nasser wrote 9,619 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,134 | 3,042 | 390 | $14K |
| Bisoprolol-Hydrochlorothiazide Bisoprolol/Hydrochlorothiazide | 711 | 1,776 | 229 | $17K |
| Losartan Potassium Generic | 599 | 1,633 | 196 | $5,670 |
| Spironolactone Generic | 553 | 1,409 | 167 | $4,094 |
| Clopidogrel Clopidogrel Bisulfate | 509 | 1,488 | 167 | $6,466 |
| Amlodipine Besylate Generic | 481 | 1,271 | 173 | $2,266 |
| Bisoprolol Fumarate Generic | 452 | 1,119 | 138 | $15K |
| Eliquis Apixaban | 449 | 998 | 134 | $559K |
| Carvedilol Generic | 409 | 1,022 | 121 | $3,241 |
| Atorvastatin Calcium Generic | 298 | 869 | 109 | $2,923 |
| Pravastatin Sodium Generic | 283 | 722 | 99 | $3,051 |
| Rosuvastatin Calcium Generic | 228 | 601 | 77 | $3,122 |
| Furosemide Generic | 189 | 486 | 69 | $936 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 175 | 463 | 57 | $2,374 |
| Hydrochlorothiazide Generic | 159 | 383 | 51 | $843 |
Brand drugs: 893 claims; generic drugs: 8,726 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ali Nasser $683 ($683 in general payments such as food, travel and fees) from 13 companies. The largest payer was Merck Sharp & Dohme LLC with $171.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 9 | $171 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $82.72 |
| Pfizer Inc. PFE | 3 | $73.59 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $73.33 |
| Philips North America LLC PHG | 2 | $55.89 |
| Kestra Medical Technology Services, Inc. | 2 | $47.28 |
| Edwards Lifesciences Corporation EW | 1 | $37.55 |
| Amgen Inc. AMGN | 2 | $34.94 |
| Abiomed JNJ | 1 | $26.4 |
| Abbott Laboratories ABT | 1 | $24.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.